Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EZH2-regulated immune risk score prognostic model predicts outcome of clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 36760869 | PubTator, text mining | PubMed |
| Distinct Prognostic and Immunological Roles of ETS1 and ETS2: A Pan-Cancer Analysis. | Biomed Res Int | 2023 | 36760475 | PubTator, text mining | PubMed |
| Regulatory T cells (Tregs) in liver fibrosis. | Cell Death Discov | 2023 | 36759593 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer. | Int J Gen Med | 2023 | 36756390 | PubTator, text mining | PubMed |
| Thirdhand Smoke May Promote Lung Adenocarcinoma Development through HN1. | Comput Math Methods Med | 2023 | 36756386 | PubTator, text mining | PubMed |
| The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma. | Front Genet | 2023 | 36755568 | PubTator, text mining | PubMed |
| CXCR3 predicts the prognosis of endometrial adenocarcinoma. | BMC Med Genomics | 2023 | 36750966 | PubTator, text mining | PubMed |
| Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. | Nat Commun | 2023 | 36750562 | PubTator, text mining | PubMed |
| Targeting Cbl-b in cancer immunotherapy. | J Immunother Cancer | 2023 | 36750253 | PubTator, text mining | PubMed |
| Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance. | Nat Commun | 2023 | 36739462 | PubTator, text mining | PubMed |
| Regulatory cells and the effect of cancer immunotherapy. | Mol Cancer | 2023 | 36739406 | PubTator, text mining | PubMed |
| DNA methylation of GITR, OX40, 4-1BB, CD27 , and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma. | Melanoma Res | 2023 | 36735464 | PubTator, text mining | PubMed |
| Propolis anti-inflammatory effects on MAGE-1 and retinoic acid-treated dendritic cells and on Th1 and T regulatory cells. | J Venom Anim Toxins Incl Trop Dis | 2023 | 36721426 | PubTator, text mining | PubMed |
| Reprogramming the tumor microenvironment with biotechnology. | Biomater Res | 2023 | 36721212 | PubTator, text mining | PubMed |
| Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma. | BMC Cancer | 2023 | 36717792 | PubTator, text mining | PubMed |
| MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma. | iScience | 2023 | 36713263 | PubTator, text mining | PubMed |
| Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment. | CPT Pharmacometrics Syst Pharmacol | 2023 | 36710369 | PubTator, text mining | PubMed |
| ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation. | Sci Rep | 2023 | 36709331 | PubTator, text mining | PubMed |
| The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma. | Clin Epigenetics | 2023 | 36707882 | PubTator, text mining | PubMed |
| JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells. | Cell Rep | 2023 | 36701231 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=35